Citations

Showing 10 of 108083 citations.

Dermoscopic Findings of Irritant “Poral” Reactions to Cobalt During Patch Testing
Yang, Yul W. , Costello, Collin M. , Mangold, Aaron R. , Mangold, A R , Costello, Collin M

Mayo Clinic

Dermatitis® | October 22, 2017 | Volume: 28 | Issue: 6 | Pages: 367-367

10.1097/der.0000000000000322 | PMID 29059096 Get It

Histopathology of Calciphylaxis: Cohort Study With Clinical Correlations
Chen, Tiffany , Lehman, Julia S. , Gibson, Lawrence E. , Lohse, Christine M. , Chen, Tiffany Y, Lehman, Julia S , el‐Azhary, Rokea A.

Mayo Clinic

The American Journal of Dermatopathology | October 22, 2017 | Volume: 39 | Issue: 11 | Pages: 795-802

10.1097/dad.0000000000000824 | PMID 29053546 Get It

Abstract: Calciphylaxis is a rare, painful, and life-threatening condition with a high mortality rate. Although the etiology of calciphylaxis is not well understood, it has been proposed that calcium deposition within and around subcutaneous vessels restricts blood flow chronically, thereby predisposing the patient to acute pannicular and dermal thrombosis. Given increasing recognition of the role of hypercoagulability in calciphylaxis, this retrospective cohort study sought to evaluate the presence of thromboses and dermal angioplasia in calciphylaxis. Moreover, we aimed to validate previous observations about the histopathology of calciphylaxis compared with skin biopsies from patients with end-stage renal disease but without calciphylaxis. After a meticulous clinical chart review, we assessed the corresponding skin biopsies for the presence of vessel calcification, thromboses, and dermal angioplasia in skin biopsies from patients with calciphylaxis (n = 57) and compared with those from patients with end-stage renal disease but without calciphylaxis (n = 26). Histopathologic findings were correlated with clinical features such as chronic kidney disease, diabetes, or associated malignancy. Our results validated a prior observation that calciphylaxis was significantly more likely to show calcification of dermal vessels and diffuse dermal thrombi. This study reports the frequent finding of dermal angioplasia, a potential marker of chronic low-grade ischemia, as another frequent microscopic finding in calciphylaxis. Among cases of calciphylaxis, histopathologic changes in patients with chronic kidney disease were indistinguishable from those in patients without chronic kidney disease, thereby implying a final common pathogenic pathway in both uremic and nonuremic calciphylaxis. In future, larger, prospective studies may be useful in validating these findings.
Chronic subthreshold cortical stimulation for adult drug-resistant focal epilepsy: safety, feasibility, and technique
Kerezoudis, Panagiotis , Stead, Matthew, Shin, Cheolsu, Cascino, Gregory D. , Brinkmann, Benjamin H. , Lundstrom, Brian Nils, Brinkmann, Benjamin H , Grewal, Sanjeet S. , Lundstrom, Brian N. , Britton, Jeffrey W. , Worrell, Gregory A. , Gompel, Jamie J. Van

Mayo Clinic

Journal of Neurosurgery | October 20, 2017 | Volume: 129 | Issue: 2 | Pages: 533-543

10.3171/2017.5.jns163134 | PMID 29053073 Get It

OBJECTIVEEpilepsy surgery is effective for lesional epilepsy, but it can be associated with significant morbidity when seizures originate from eloquent cortex that is resected. Here, the objective was to describe chronic subthreshold cortical stimulation and evaluate its early surgical safety profile in adult patients with epilepsy originating from seizure foci in cortex that is not amenable to resection.METHODSAdult patients with focal drug-resistant epilepsy underwent intracranial electroencephalography monitoring for evaluation of resection. Those with seizure foci in eloquent cortex were not candidates for resection and were offered a short therapeutic trial of continuous subthreshold cortical stimulation via intracranial monitoring electrodes. After a successful trial, electrodes were explanted and permanent stimulation hardware was implanted.RESULTSTen patients (6 males) who underwent chronic subthreshold cortical stimulation between 2014 and 2016 were included. Based on radiographic imaging, intracranial pathologies included cortical dysplasia (n = 3), encephalomalacia (n = 3), cortical tubers (n = 1), Rasmussen encephalitis (n = 1), and linear migrational anomaly (n = 1). The duration of intracranial monitoring ranged from 3 to 20 days. All patients experienced an uneventful postoperative course and were discharged home with a median length of stay of 10 days. No postoperative surgical complications developed (median follow-up length 7.7 months). Seizure severity and seizure frequency improved in all patients.CONCLUSIONSThe authors’ institutional experience with this small group shows that chronic subthreshold cortical stimulation can be safely and effectively performed in appropriately selected patients without postoperative complications. Future investigation will provide further insight to recently published results regarding mechanism and efficacy of this novel and promising intervention.
Iterative Implementation of a Remote Cardiac Patient Monitoring Device using Qualitative Analysis and Human Factors Engineering
Lowndes, Bethany R. , Finnie, Dawn, Hathaway, Julie, Vickers-Douglas, Kristin S., Finnie, Dawn M., Ridgeway, Jennifer L. , Bruce, Charles J. , Hallbeck, M. Susan

Mayo Clinic

Proceedings of the Human Factors and Ergonomics Society Annual Meeting | October 20, 2017 | Volume: 61 | Issue: 1 | Pages: 1081-1085

10.1177/1541931213601874 Get It

Remote monitoring has the potential to improve patient care and satisfaction while reducing the cost of care and burden on the healthcare system for Congestive Heart Failure (CHF) and Atrial Fibrillation (AF) patients. However, the device must be convenient and easy for the population to use correctly. In this study, human factors and qualitative researchers evaluated the use of a remote cardiac monitoring device during a clinical trial with 74 CHF and AF patients. Human factors usability concerns centered on device use and the information presented in the manual. The key themes identified during the qualitative analysis were related to patient education. These findings were incorporated into device design, user manual, or education material updates. This study illustrates how these methods can infuse patient experience into device design to inform continued quality improvement and usability refinement specifically in devices to aid CHF and AF patients without added burden.
A Preliminary Comparison of Three Tourniquet Instructions for Just-in-Time Guidance of a Simulated Tourniquet Application
Lowndes, Bethany R. , Forsyth, Katherine L., Johnson, Carl-Oscar, Abdelrahman, Amro M. , Sztajnkrycer, Matthew D. , Franz, Walter B., Blocker, Renaldo C., Forsyth, Katherine L., Prytz, Erik , Hallbeck, M. Susan , Abdelrahman, Amro M

Mayo Clinic

Proceedings of the Human Factors and Ergonomics Society Annual Meeting | October 20, 2017 | Volume: 61 | Issue: 1 | Pages: 1076-1080

10.1177/1541931213601873 Get It

The American College of Surgeons (ACS) and the Department of Homeland Security (DHS) encourage the use of tourniquets as part of the “Stop the Bleed” campaign. Both have provided instructions for layperson tourniquet application in order to save the life of a hemorrhaging trauma victim. This study sought to compare the impact of using ACS and DHS instructions with manufacturer-provided instructions for the completion of simulated tourniquet application steps. Thirty surgical trainees completed a simulated tourniquet application with one of the three instruction sets. Their completion time and success for each step were measured. Participants that received ACS instructions failed the fewest number of steps (p < 0.01) and completed the task faster (Mean (SD) = 70 (33) seconds) compared to those with the manufacturer-provided instructions (p < 0.01). Tourniquet instruction sets need to be refined in order to optimize the success rate of just-in-time guidance for tourniquet application.
Ixazomib significantly prolongs progression-free survival in high-risk relapsed/refractory myeloma patients
Avet‐Loiseau, Hervé , Masszi, Tamás , Viterbo, Luísa, Pour, Luděk, Palumbo, Antonio , Cavo, Michèle , Langer, Christian , Pluta, Andrzej, Nagler, Arnon , Kumar, Shaji , Ben‐Yehuda, Dina, Miguel, Jesús F. San , Berg, Deborah, Lin, Jianchang , Velde, Helgi van de , Esseltine, Dixie‐Lee, Bacco, Alessandra Di , Moreau, Philippe , Richardson, Paul G. , Moreau, Philippe , San-Miguel, Jesus , Masszi, Tamas , Bahlis, Nizar Jacques , Chng, Wee Joo , Ganly, Peter S. , Rajkumar, S. Vincent , Esseltine, Dixie‐Lee, Richardson, Paul Gerard Guy

Mayo Clinic

Blood | October 20, 2017 | Volume: 130 | Issue: 24 | Pages: 2610-2618

10.1182/blood-2017-06-791228 | PMID 29054911 Get It

Key Points IRd was associated with a consistent PFS benefit vs placebo-Rd in RRMM patients with high-risk and standard-risk cytogenetics. The addition of ixazomib to Rd overcomes the poor PFS associated with high-risk cytogenetics in patients with RRMM.
Pharmacogenomic Discovery to Function and Mechanism: Breast Cancer as a Case Study
Wang, Liewei , Weinshilboum, Richard M. , Ingle, James, Weinshilboum, Richard, Ingle, James N. , Weinshilboum, Richard M.

Mayo Clinic

Clinical Pharmacology & Therapeutics | October 20, 2017 | Volume: 103 | Issue: 2 | Pages: 243-252

10.1002/cpt.915 | PMID 29052219 Get It

Biomedical research is undergoing rapid change, with the development of a series of analytical omics techniques that are capable of generating Biomedical Big Data. These developments provide an unprecedented opportunity to gain novel insight into disease pathophysiology and mechanisms of drug action and response—but they also present significant challenges. Pharmacogenomics is a discipline within Clinical Pharmacology that has been at the forefront in defining, taking advantage of, and dealing with the opportunities and challenges of this aspect of the Post‐Genome Project world. This overview will describe the evolution of germline pharmacogenomic research strategies as we have moved from an era of candidate genes to agnostic genome‐wide association studies (GWAS) coupled with the functional and mechanistic pursuit of GWAS signals. Germline pharmacogenomic studies of breast cancer endocrine therapy will be used to illustrate research strategies that are being applied broadly to omics studies of drug response phenotypes.
[P1–334]: CHARACTERIZATION OF THE CLINICAL AND NEUROIMAGING FEATURES OF PATIENTS WITH DEMENTIA WITH LEWY BODIES ASSOCIATED WITH VARIANTS IN GLUCOCEREBROSIDASE (GBA)
Graff‐Radford, Neill R. , Radford, Jonathan Graff, Savica, Rodolfo , Przybelski, Scott A. , Lowe, Val J. , Petersen, Ronald C. , Boeve, Bradley F. , Ross, Owen A. , Kantarci, Kejal , Ferman, Tanis J. , Jones, David T. , Mielke, Michelle M. , Knopman, David S. , Jack, Clifford R.

Mayo Clinic

Alzheimer's & Dementia | October 20, 2017 | Volume: 13 | Issue: 7S_Part_7 | Pages: No page available

10.1016/j.jalz.2017.06.350 Get It

[P4–278]: DISTINCT ULTRASTRUCTURAL CHARACTERISTICS OF CAPILLARY BASAL LAMINA IN HUMAN AND MOUSE BRAINS: RELEVANCE TO MURINE MODELS OF NEUROVASCULAR DISEASE
Lin, Wen‐Lang, Dickson, Dennis W.

Mayo Clinic

Alzheimer's & Dementia | October 20, 2017 | Volume: 13 | Issue: 7S_Part_29 | Pages: No page available

10.1016/j.jalz.2017.06.2147 Get It

[P4–106]: GENETIC MUTATIONS IN MAPT AND SIGNIFICANT VARIABILITY IN TAU PROTEIN MODIFICATIONS INDICATE THE EXISTANCE OF A WIDE ARRAY OF STRAINS WITHIN AND ACROSS PRIMARY AND SECONDARY TAUOPATHIES
DeTure, Michael , Tacik, Paweł , Carlomagno, Yari , Ross, Kelly , Kouri, Naomi , Murray, Melissa E. , Dickson, Dennis W.

Mayo Clinic

Alzheimer's & Dementia | October 20, 2017 | Volume: 13 | Issue: 7S_Part_27 | Pages: No page available

10.1016/j.jalz.2017.06.1972 Get It